COVID-19 Vaccine Eligibility and Booking Guidelines

We are a COVID-19 Vaccination Site image


Medical Associates of Port Perry is pleased to be included in the list of providers to offer COVID-19 vaccine to eligible patients. Appointments can be booked online by clicking the link below or by calling 905-985-2895 ext. 6070. We will not be accepting walk-ins at this time.


  • We are currently running clinics for patients 12 years of age and up
    • 4th dose vaccines are available to individuals 18 years of age and older
    • 5th dose vaccines are available to moderately to severely immunocompromised individuals 18 years of age and over
  • A minimum of 140 days after THIRD dose and/or 90 days after having Covid
  • Pfizer vaccine is preferentially recommended for those aged 12 to 29 at vaccine clinics across Durham Region.
  • For paediatric vaccines (under 12 years of age) please visit the website durhamvaccinebookings.ca to book an appointment with Durham Public Health

Please review eligibility criteria prior to booking your
COVID-19 Vaccine appointment.

We are currently booking 1st, 2nd, 3rd & 4th dose COVID vaccines.

Eligibility Criteria for COVID-19 Vaccines

All residents age 5 +

  • Effective, January 1, 2022, individuals must be 12 years old at time of vaccination to receive adult dose of Pfizer vaccine.
  • Children 5 to 11-years old are eligible to receive the paediatric Pfizer COVID-19 vaccine based on their birth date. Children must be at least 5 years of age at the time of immunization.

Eligibility Criteria for COVID-19 Vaccines


Third and Fourth doses (boosters)

The Ontario government has announced that the following populations are eligible for third dose COVID-19 vaccination with the vaccine product authorized for their age group.  Please click on your group below to ensure you meet eligibility requirements.

 

Age-based eligibility

Who: Individuals 18 years of age and older (must be 18 years of age at the time of immunization).

Interval criteria: A minimum of 140 days after third dose. With informed consent, individuals may receive a fourth dose at a minimum of 84 days after their third (booster) dose.

First Nation, Inuit and Métis adults (must be 16 years of age or older at the time of immunization)

Who: First Nations, Inuit and Métis individuals and their non-Indigenous household members aged 18 and older.

Interval criteria: A minimum of 140 days after third dose. With informed consent, individuals may receive a fourth dose at a minimum of 84 days after their third (booster) dose.

 

Recipients of a viral vector vaccine or series

Who:

  • Primary series completed with only viral vector vaccines
  • Individuals who received two doses of AstraZeneca/COVISHIELD COVID-19 vaccine
  • Individuals who received one dose of Janssen/Johnson & Johnson COVID-19 vaccine

Interval criteria: A minimum of 84 days after the SECOND dose

How to receive vaccine: We are currently accepting appointment bookings for eligible patients using our online booking link above or by calling the office at 905-985-2895 ext. 6070.  Many community pharmacies and the Durham Region Health Health Department are also offering appointments.

Moderately to severely immunocompromised individuals due to medical condition

Who: Individuals 12 years of age or older (must be 12 years of age or older at time of immunization), and meet at least one of the following criteria:

  • Individuals receiving dialysis (hemodialysis or peritoneal dialysis).
  • Individuals receiving active treatment (e.g., chemotherapy, targeted therapies, immunotherapy) for solid tumour or hematologic malignancies. Active treatment includes patients who have completed treatment within 3 months.
  • Recipients of solid-organ transplant and taking immunosuppressive therapy.
  • Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy).
  • Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Individuals with HIV with prior AIDS defining illness or prior CD4 count ≤ 200/mm3 or prior CD4 fraction ≤ 15%

Fourth dose interval:

  • Youth 12 to 17-years old: minimum 168 days following third dose is recommended and associated with a lower risk of myocarditis and pericarditis.
    • With informed consent, youth 12 to 17-years old may receive a booster dose at a minimum of 84 days after completion of their second dose of a 3-dose primary COVID-19 vaccine series.
  • Individuals 18 years and older: minimum 84 days following third dose.

How to receive vaccine: Before vaccination, these individuals should discuss their vaccine plans with their health care providers to check if it will affect their treatment.

Individuals receiving immunosuppressive medication

Who: Individuals 12 years of age or older (must be 12 years of age or older at time of immunization) and receiving active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies* (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids (refer to the CIG for suggested definition of high dose steroids), alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.

*Active treatment for patients receiving B-cell depleting therapy includes patients who have completed treatment within 12 months.

See Table 1: List of immunosuppressive medications

Fourth dose interval:

  • Youth 12 to 17-years old: minimum 168 days following third dose is recommended and associated with a lower risk of myocarditis and pericarditis.
    • With informed consent, youth 12 to 17-years old may receive a booster dose at a minimum of 84 days after completion of their second dose of a 3-dose primary COVID-19 vaccine series.
  • Individuals 18 years and older: minimum 84 days following third dose.

Proof of eligibility requirement: Verbally attest to receiving listed immunosuppressant medications or therapies.

How to receive vaccine: Before vaccination, these individuals should discuss their vaccine plans with their health care providers to check if it will affect their treatment.

Proof of eligibility requirements: Verbally attest to receiving listed immunosuppressant medications or therapies  

The following is needed at the appointment:

  • ID with date of birth and first/last name
  • Prescription, pharmacy record, or medication bottle that includes the prescription name, their name and pharmacy’s contact information.
  • Pharmacy records can be obtained by calling their pharmacy.
  • If you bring the medication bottle, it should be in a clear, closed, plastic bag as some medication can be harmful to others and may require special handling.
Vulnerable older adults in congregate settings

Who: Residents of long-term care homes, retirement homes, elder care lodges, and older adults living in other congregate settings (e.g., assisted-living facilities, chronic care hospitals, naturally occurring congregate retirement settings/congregate senior’s apartment buildings, older adults living in congregate settings for people with developmental disabilities, mental health and addictions issues, etc.).

Fourth dose interval: Minimum 84 days following third dose.

Proof of eligibility requirement: Verbally attest to being a resident of a listed seniors congregate living setting.

How to receive vaccine: 

  • The Health Department is working with these facilities to coordinate vaccination of residents at their residence.
  • Appointments can also be booked at a community immunization clinic by visiting durham.ca/VaccineAppointment or calling the call centre at 1-888-444-5113.